SCHEMBL20246743

SCHEMBL20246743

C=C(C)SCC(=O)NC1CCCC1

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ NPC1 O15118 4/20 0.48
▸ RAB9A P51151 4/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KMT2A Q03164 4/20 0.46
▸ HPGD P15428 8/20 0.46
▸ EPHX1 P07099 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ MITF O75030 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ LMNA P02545 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14110289 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL18613033 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL31532555 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL10085163 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL10078381 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL21340181 0.84 NPSR1 (0.53) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL2904621 0.77 L3MBTL1 (0.44) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL25894262 0.73 POLB (0.44) SMN1; SMN2NPC1RAB9ANPSR1KMT2A
SCHEMBL25894179 0.73 NPC1 (0.43) SMN1; SMN2NPC1RAB9AKMT2AHPGD
SCHEMBL2412758 0.72 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ANPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2892525-B1 METHODS OF TREATING MUSCULAR DYSTROPHY UNIV NEVADA RENO (US) 2018-06-13 — — EP disclosed
Send feedback